Free Trial

Harvard Bioscience (HBIO) Competitors

Harvard Bioscience logo
$0.41 +0.00 (+1.02%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$0.42 +0.01 (+2.72%)
As of 10/24/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HBIO vs. TMO, A, MTD, WAT, ILMN, TECH, CRL, BIO, BRKR, and PACB

Should you be buying Harvard Bioscience stock or one of its competitors? The main competitors of Harvard Bioscience include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). These companies are all part of the "life sciences tools & services" industry.

Harvard Bioscience vs. Its Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Harvard Bioscience presently has a consensus target price of $2.00, suggesting a potential upside of 390.32%. Thermo Fisher Scientific has a consensus target price of $595.75, suggesting a potential upside of 3.96%. Given Harvard Bioscience's higher possible upside, equities analysts plainly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Harvard Bioscience
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Thermo Fisher Scientific
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.79

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.5% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harvard Bioscience$94.14M0.19-$12.40M-$1.30-0.31
Thermo Fisher Scientific$42.88B5.05$6.34B$17.3133.11

Thermo Fisher Scientific has a net margin of 15.02% compared to Harvard Bioscience's net margin of -64.68%. Thermo Fisher Scientific's return on equity of 16.97% beat Harvard Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Harvard Bioscience-64.68% -5.64% -2.15%
Thermo Fisher Scientific 15.02%16.97%8.49%

In the previous week, Thermo Fisher Scientific had 97 more articles in the media than Harvard Bioscience. MarketBeat recorded 99 mentions for Thermo Fisher Scientific and 2 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 1.89 beat Thermo Fisher Scientific's score of 1.10 indicating that Harvard Bioscience is being referred to more favorably in the media.

Company Overall Sentiment
Harvard Bioscience Very Positive
Thermo Fisher Scientific Positive

Harvard Bioscience has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 12 of the 16 factors compared between the two stocks.

Get Harvard Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HBIO vs. The Competition

MetricHarvard BioscienceINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$18.16M$1.02B$33.67B$10.81B
Dividend YieldN/A0.51%3.18%4.81%
P/E Ratio-0.3128.66105.6630.95
Price / Sales0.191.111,290.97133.74
Price / Cash4.0417.1238.6161.86
Price / Book0.282.217.626.61
Net Income-$12.40M$17.67M$820.47M$277.10M
7 Day Performance7.54%3.57%2.47%2.57%
1 Month Performance-7.13%3.62%3.63%3.79%
1 Year Performance-82.42%-14.07%24,146.25%33.01%

Harvard Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HBIO
Harvard Bioscience
4.0561 of 5 stars
$0.41
+1.0%
$2.00
+390.3%
-82.6%$18.16M$94.14M-0.31490Positive News
Analyst Forecast
TMO
Thermo Fisher Scientific
4.7564 of 5 stars
$524.80
flat
$589.10
+12.3%
+2.8%$198.17B$42.88B30.35125,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
A
Agilent Technologies
3.7446 of 5 stars
$138.43
+1.3%
$148.69
+7.4%
+13.2%$38.73B$6.51B32.4917,900Positive News
Analyst Forecast
MTD
Mettler-Toledo International
4.091 of 5 stars
$1,289.13
+1.2%
$1,336.50
+3.7%
+11.0%$26.24B$3.87B32.6417,300News Coverage
Positive News
Analyst Forecast
Analyst Revision
WAT
Waters
4.1196 of 5 stars
$336.83
+1.8%
$377.56
+12.1%
+9.6%$19.70B$2.96B30.377,600Trending News
Analyst Forecast
ILMN
Illumina
4.6928 of 5 stars
$95.03
+1.2%
$123.56
+30.0%
-29.2%$14.43B$4.37B12.039,030Upcoming Earnings
Analyst Forecast
TECH
Bio-Techne
4.3783 of 5 stars
$59.65
+1.7%
$70.17
+17.6%
-3.6%$9.13B$1.22B129.683,100Positive News
Analyst Forecast
CRL
Charles River Laboratories International
4.2919 of 5 stars
$170.85
+2.3%
$179.93
+5.3%
+8.1%$8.22B$4.05B-128.4620,100Analyst Downgrade
BIO
Bio-Rad Laboratories
4.4228 of 5 stars
$303.56
+2.0%
$333.50
+9.9%
+3.7%$8.06B$2.57B25.887,700News Coverage
Upcoming Earnings
BRKR
Bruker
4.9093 of 5 stars
$36.23
+2.7%
$51.00
+40.8%
-33.2%$5.35B$3.37B69.6711,396News Coverage
Analyst Forecast
Analyst Revision
PACB
Pacific Biosciences of California
0.7493 of 5 stars
$1.62
+14.1%
$1.90
+17.3%
+17.4%$426.53M$154.01M-0.71730Analyst Forecast
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:HBIO) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners